Molecular Dynamics Simulations Elucidate the Molecular Organization of Poly(beta-amino ester) Based Polyplexes for siRNA Delivery
Source abstract
Abstract
Cationic polymers are known to efficiently deliver nucleic acids to target cells by encapsulating the cargo into nanoparticles. However, the molecular organization of these nanoparticles is often not fully explored. Yet, this information is crucial to understand complex particle systems and the role influencing factors play at later stages of drug development. Coarse-grained molecular dynamics (CG-MD) enables modeling of systems that are the size of real nanoparticles, providing meaningful insights into molecular interactions between polymers and nucleic acids. Herein, the particle assembly of variations of an amphiphilic poly(beta-amino ester) (PBAE) with siRNA was simulated to investigate the influence of factors such as polymer lipophilicity and buffer conditions on the nanoparticle structure. Simulations were validated by wet lab methods including nuclear magnetic resonance (NMR) and align well with experimental findings. Therefore, this work emphasizes that CG-MD simulations can provide underlying explanations of experimentally observed nanoparticle properties by visualizing the nanoscale structure of polyplexes.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacy, Ludwig-Maximilians-University Munich, 81377 Munich, Germany
Department of Chemistry, Ludwig-Maximilians-University Munich, 81377 Munich, Germany
Center for NanoScience (CeNS), Ludwig-Maximilians-University Munich, 80799 Munich, Germany
Comprehensive Pneumology Center Munich (CPC-M), Helmholtz Munich, German Center for Lung Research (DZL), 81377 Munich, Germany
Funding
HORIZON EUROPE European Research Council
References (55)
Show source-provided references
1. 10.1124/jpet.122.00123410.1124/jpet.122.001234 ↗
2. 10.2217/nmt-2018-003310.2217/nmt-2018-0033 ↗
3. 10.1056/NEJMoa191314710.1056/NEJMoa1913147 ↗
4. 10.1056/NEJMoa202171210.1056/NEJMoa2021712 ↗
5. 10.1056/NEJMoa191238710.1056/NEJMoa1912387 ↗
6. 10.1089/nat.2023.006810.1089/nat.2023.0068 ↗
7. 10.1021/nn301966r10.1021/nn301966r ↗
8. 10.1002/adhm.20210214510.1002/adhm.202102145 ↗
9. 10.1016/j.jconrel.2014.06.00910.1016/j.jconrel.2014.06.009 ↗
10. 10.1016/j.jconrel.2024.01.02610.1016/j.jconrel.2024.01.026 ↗
11. 10.3390/pharmaceutics1601015410.3390/pharmaceutics16010154 ↗
12. 10.1002/adhm.20200189410.1002/adhm.202001894 ↗
13. 10.3390/pharmaceutics1302022310.3390/pharmaceutics13020223 ↗
14. 10.1517/17425247.2013.74496410.1517/17425247.2013.744964 ↗
15. 10.1038/sj.gt.330242510.1038/sj.gt.3302425 ↗
16. 10.1016/j.jconrel.2013.08.00510.1016/j.jconrel.2013.08.005 ↗
17. 10.1080/17425247.2020.179662810.1080/17425247.2020.1796628 ↗
18. 10.1021/ja001538810.1021/ja0015388 ↗
19. 10.1021/ja034429c10.1021/ja034429c ↗
20. 10.1002/adma.20120434610.1002/adma.201204346 ↗
21. 10.1021/acs.biomac.4c0028310.1021/acs.biomac.4c00283 ↗
22. 10.1016/j.jconrel.2022.12.00810.1016/j.jconrel.2022.12.008 ↗
23. 10.7554/eLife.5201210.7554/eLife.52012 ↗
24. 10.1021/acs.biomac.2c0033810.1021/acs.biomac.2c00338 ↗
25. 10.1016/j.jconrel.2011.08.02310.1016/j.jconrel.2011.08.023 ↗
26. 10.1021/acsami.3c0501010.1021/acsami.3c05010 ↗
27. 10.1021/acs.molpharmaceut.3c0074710.1021/acs.molpharmaceut.3c00747 ↗
28. 10.1021/jp911906e10.1021/jp911906e ↗
29. 10.3390/polym1420440910.3390/polym14204409 ↗
30. 10.1039/D0NR09052B10.1039/D0NR09052B ↗
31. 10.1021/acs.jpcb.2c0767110.1021/acs.jpcb.2c07671 ↗
32. 10.1038/s41592-021-01098-310.1038/s41592-021-01098-3 ↗
33. 10.1016/j.jconrel.2024.02.00210.1016/j.jconrel.2024.02.002 ↗
34. 10.1002/adhm.20247007810.1002/adhm.202470078 ↗
35. 10.1021/acs.jctc.2c0095010.1021/acs.jctc.2c00950 ↗
36. 10.1002/jgm.59810.1002/jgm.598 ↗
37. 10.1039/D3NA00272A10.1039/D3NA00272A ↗
38. 10.1002/mabi.20130004610.1002/mabi.201300046 ↗
39. 10.1021/mz400500q10.1021/mz400500q ↗
40. 10.1021/acs.langmuir.7b0401510.1021/acs.langmuir.7b04015 ↗
41. 10.1002/jmr.227410.1002/jmr.2274 ↗
42. 10.1021/cr00104a00210.1021/cr00104a002 ↗
43. 10.1016/0006-291X(80)90695-610.1016/0006-291X(80)90695-6 ↗
44. Levitt M. H. · 2008
45. 10.1016/j.cpc.2015.09.01410.1016/j.cpc.2015.09.014 ↗
46. 10.1146/annurev.biophys.28.1.15510.1146/annurev.biophys.28.1.155 ↗
47. 10.1016/j.molliq.2021.11793010.1016/j.molliq.2021.117930 ↗
48. 10.1007/s13346-019-00637-y10.1007/s13346-019-00637-y ↗
49. 10.1016/S0939-6411(02)00081-410.1016/S0939-6411(02)00081-4 ↗
50. 10.1016/j.ejpb.2018.05.03410.1016/j.ejpb.2018.05.034 ↗
51. 10.1038/mt.2012.18510.1038/mt.2012.185 ↗
52. 10.1016/j.ijpharm.2023.12325710.1016/j.ijpharm.2023.123257 ↗
53. 10.1016/j.actbio.2015.03.02910.1016/j.actbio.2015.03.029 ↗
54. 10.1021/nn403069n10.1021/nn403069n ↗
55. 10.3389/fchem.2023.110649510.3389/fchem.2023.1106495 ↗